Larvol Delta - Targeting-Endothelial-Dysfunction-in-Eight-ExtremeCritically-Ill-Patients-with-COVID19-Using-the-AntiAdrenomedullin-Antibody-Adrecizumab-HAM8101

adrecizumab (HAM 8101) - Adrenomed

http://www.ncbi.nlm.nih.gov/pubmed/32796765

Aug 17, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next